M&G plc’s HCA Healthcare HCA Stock Holding History

M&G plc’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-29,575	Closed	-$8.87M	–	457
2024 Q4	$8.87M	Buy	+29,575	New	+$10.3M	0.05%	243

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

M&G plc's HCA Position: Q1 2025 in Review

M&G plc sold out of HCA Healthcare (HCA) in Q1 2025, closing a stake of 29,575 shares — an estimated $8.87M sold.

M&G plc first reported a position in HCA in Q4 2024 and held it in 1 quarter. The position peaked at $8.87M in Q4 2024. 1,224 funds tracked by Wall St. Rank hold HCA as of Q1 2025.

M&G plc reported no remaining HCA Healthcare position as of Q1 2025 after selling out during the quarter.
M&G plc sold 29,575 HCA Healthcare shares in Q1 2025, an estimated $8.87M.
M&G plc first reported a position in HCA Healthcare in Q4 2024 and held it in 1 quarter.
M&G plc's HCA Healthcare position peaked at $8.87M in Q4 2024.
1,224 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2025.

Based on M&G plc's 13F filing for Q1 2025, filed 13 May 2025.